Veda Giri, MD, on innovative approaches to genetic testing in prostate cancer
In a recent interview with Urology Times®, Veda N. Giri, MD, outlined alternative care models that could help…
Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer
Data from a large real-world analysis presented at the American Society for Radiation Oncology 67th Annual Meeting1 suggests…
Veda Giri, MD, on barriers to genetic testing in prostate cancer
In a recent interview with Urology Times®, Veda N. Giri, MD, outlined some of the key barriers to…
FDA grants clearance to BioTraceIO360 for kidney ablation
The FDA has granted 510(k) clearance to the BioTraceIO360 software platform for use in percutaneous ablation of soft…
bpMRI is found noninferior to mpMRI in prostate cancer
In this video, Veeru Kasivisvanathan, MBBS, BSc, FRCS, MSc, PGCert, PhD, discussed findings from the PRIME trial, a…